Back

Assessing the efficacy of human mesenchymal stromal cells of different tissue origins in a mouse model of kidney ischaemia reperfusion injury

Trivino-Cepeda, K.; Amadeo, F.; Hughes, D. M.; Ressel, L.; Garcia-Finana, M.; Hanson, V.; Taylor, A.; Murray, P. A.; Wilm, B.

2026-06-20 physiology
10.64898/2026.06.19.733188 bioRxiv
Show abstract

Rodent models of kidney disease have been widely used to assess the efficacy, safety and mode of action of mesenchymal stromal cells (MSCs) as therapies. However, because kidney disease models, MSC type and the methods used to assess kidney injury tend to differ between research groups, it is difficult to obtain data that are sufficiently robust and reproducible to support clinical translation. We present here for the first time a side-by-side analysis of the performance of human MSCs derived from the most commonly used tissue sources, bone marrow (BM-), adipose- (A-) and umbilical cord (UC-), in a kidney ischaemia reperfusion injury (IRI) model in mice. For each animal, we performed a comprehensive assessment of kidney function and health by longitudinal transdermal measurements of sinistrin clearance, serum biomarker levels at the experimental endpoint, and histopathological scoring of sections from left and right kidneys. Furthermore, we tracked the MSCs by bioluminescence imaging in the injured mice to determine their viability over time and their capacity for homing to the damaged kidneys. Our results reveal that only modest if any beneficial effects of the MSC treatments were detectable on kidney function and histology, irrespective of cell type administered. Furthermore, all three MSC types were sequestered in the lungs without reaching the kidneys, and had completely disappeared within 7 days. Our data suggest that none of the MSC types has the capability to improve renal health following IRI to a meaningful extent, questioning their suitability as a clinical therapy. Significance StatementMSCs have been proposed as efficacious cell therapies in murine models of kidney disease, with potential for clinical translation. We compare efficacy of human MSCs of different tissue origins (adipose, bone marrow and umbilical cord) in a refined mouse model of renal IRI. Only modest if any beneficial effects on kidney function and histology were detectable for all three cell types, and cells did not reach the kidneys but sequestered in the lungs where they died.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Kidney International
29 papers in training set
Top 0.1%
19.3%
2
American Journal of Transplantation
18 papers in training set
Top 0.1%
15.7%
3
PLOS ONE
5266 papers in training set
Top 20%
9.3%
4
Kidney360
22 papers in training set
Top 0.1%
7.6%
50% of probability mass above
5
Scientific Reports
3612 papers in training set
Top 14%
5.7%
6
American Journal of Physiology-Renal Physiology
28 papers in training set
Top 0.1%
5.4%
7
BMC Nephrology
18 papers in training set
Top 0.2%
2.9%
8
Journal of the American Society of Nephrology
56 papers in training set
Top 0.3%
2.9%
9
JCI Insight
277 papers in training set
Top 5%
1.6%
10
Acta Physiologica
17 papers in training set
Top 0.2%
1.6%
11
Diabetologia
44 papers in training set
Top 0.5%
1.6%
12
Kidney International Reports
15 papers in training set
Top 0.2%
1.2%
13
Nature Communications
5641 papers in training set
Top 50%
1.2%
14
Stem Cell Research
16 papers in training set
Top 0.2%
1.1%
15
Frontiers in Bioengineering and Biotechnology
98 papers in training set
Top 2%
1.0%
16
Cells
249 papers in training set
Top 6%
1.0%
17
Frontiers in Immunology
638 papers in training set
Top 8%
1.0%
18
American Journal of Physiology-Cell Physiology
39 papers in training set
Top 0.7%
0.9%
19
Fluids and Barriers of the CNS
28 papers in training set
Top 0.5%
0.9%
20
Cardiovascular Research
37 papers in training set
Top 1%
0.9%
21
BMJ Open Diabetes Research & Care
16 papers in training set
Top 0.5%
0.6%
22
BMJ Open
601 papers in training set
Top 13%
0.6%
23
Frontiers in Medicine
120 papers in training set
Top 5%
0.6%
24
Journal of Bioinformatics and Systems Biology
15 papers in training set
Top 0.3%
0.6%
25
Physiological Reports
40 papers in training set
Top 1%
0.6%
26
European Respiratory Journal
59 papers in training set
Top 1%
0.6%
27
eLife
5828 papers in training set
Top 67%
0.6%
28
Clinical Journal of the American Society of Nephrology
10 papers in training set
Top 0.2%
0.6%
29
Stem Cells
31 papers in training set
Top 0.9%
0.5%
30
The FASEB Journal
194 papers in training set
Top 7%
0.5%